Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort “Visages”

Overview of attention for article published in Orphanet Journal of Rare Diseases, June 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 41 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Therapie primärer Antikörpermangelerkrankungen: Langfassung der Leitlinie "Therapie primärer Antikörpermangelerkrankungen"

Cited by The Association of the Scientific Medical Societies in Germany on 04 Jan 2019

The Association of the Scientific Medical Societies in Germany (AWMF) is an umbrella organization of over 150 societies, and advises the government of the Federal Republic of Germany as well as the governments of the German federal countries in all topics of scientific medicine and medical research and classification.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.